What is MapLight Therapeutics, Inc. 's enterprise value?

MapLight Therapeutics, Inc. (MPLT) reported enterprise value of $812.61M in Q1 2026.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

MapLight Therapeutics, Inc. MPLT Enterprise value

Enterprise value at other companies

Bristol-Myers SquibbBMY

$158.92B-2.6%

Johnson & JohnsonJNJ

$622.06B+50.5%

Neurocrine BiosciencesNBIX

$13.41B+18.5%

Acadia PharmaceuticalsACAD

$3.56B+36.6%

AbbVieABBV

$460.96B+24.7%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$389.92M—

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Calculated from MapLight Therapeutics, Inc. ’s reported figures.

$862.7Mmarket cap+$5.6Mtotal debt−$55.7Mcash and equivalents=$812.61M

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's enterprise value?: MapLight Therapeutics, Inc. (MPLT) reported enterprise value of $812.61M in Q1 2026.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.